# SAXAGLIPTIN
> **ANDA205941** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-07-31
## Drug
- **FDA Application Number:** ANDA205941
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAXAGLIPTIN
- **Generic name:** Saxagliptin Hydrochloride
- **Active ingredients:** SAXAGLIPTIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AMNEAL
- **First approval:** 2023-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205941)
---
*AI Analytics · CC0 1.0*